mouse (Kon et al., 2017; Sasaki et al., 2018) in vivo. In this process, normal epithelial cells recognize the presence of the neighboring transformed cells and actively eliminate them from epithelia, implying that normal epithelia have antitumor activity that does not involve immune cells, which is termed EDAC (epithelial defense against cancer) (Kajita et al., 2014) . However, the underlying molecular mechanisms still remain largely obscure.
Non-muscle myosin-II binds to actin and generates mechanical forces, thereby regulating various cellular processes such as cell migration, cytokinesis, and cell shape changes (Heissler & Manstein, 2013; Pecci, Ma, Savoia, & Adelstein, 2018; Vicente-Manzanares, Ma, Adelstein, & Horwitz, 2009) . Myosin-II consists of a homodimer of heavy chains, two regulatory light chains, and two essential light chains, and activity of myosin-II is regulated by phosphorylation of regulatory light chains. Mammalian cells express three isoforms of non-muscle myosin-II, NM IIA, IIB, and IIC, which differ in their heavy chains; among them, NM IIA is most widely distributed in tissues. To investigate the competitive interaction between normal and transformed cells, we have established Madin-Darby canine kidney (MDCK) epithelial cells stably expressing oncogenic cSrcY527F or RasV12 in a tetracycline-inducible manner (Hogan et al., 2009; Ohoka et al., 2015) . In Src-or Ras-transformed cells that are surrounded by normal cells, phosphorylation of myosin light chain (MLC) of myosin-II is elevated (Hogan et al., 2009; Kajita et al., 2010) . The increased MLC phosphorylation is not observed when transformed cells alone are cultured, indicating that activation of myosin-II is induced by the presence of the neighboring normal cells in a non-cell-autonomous manner. Addition of the myosin-II inhibitor blebbistatin or expression of the dominant-negative form of MLC (MLC-AA) in transformed cells suppresses apical extrusion (Hogan et al., 2009; Kajita et al., 2010) , indicating that activity of myosin-II plays a crucial role in the elimination of transformed cells.
In this study, we demonstrate that not only activity of myosin-II but also its accumulation is involved in apical extrusion of transformed cells.
| RESULTS

| Accumulation of myosin-IIA plays a positive role in apical extrusion of Srctransformed cells
To further understand the role of myosin-II in apical extrusion of Src-transformed cells, we examined the localization of heavy chains of myosin-II (NMHC-IIA: non-muscle myosin heavy chain IIA) by immunofluorescence. When Src-transformed cells were surrounded by normal epithelial cells, NMHC-IIA was profoundly accumulated at the apical side of Src cells (Figure 1a,b) . When Src-transformed cells alone were present, the accumulation of NMHC-IIA was not observed, and the immunofluorescence level of NMHC-IIA was comparable to that in normal cells (Figure 1a,b) , suggesting that the presence of the neighboring normal cells induces accumulation of NMHC-IIA in Src cells in a noncell-autonomous fashion. These results imply that not only activity of myosin-II (Hogan et al., 2009; Kajita et al., 2010) but also accumulation of myosin-II is regulated during apical extrusion. Accumulation of NMHC-IIA also occurred in RasV12-transformed cells that were surrounded by normal cells (Supporting Information Figure S1a ,b), but less prominently than that in Src-transformed cells; therefore, in this study, we focused on the functional role of myosin-II in apical extrusion of Src-transformed cells.
Previous studies have shown that F-actin is not accumulated in Src-or RasV12-transformed cells that are surrounded by normal cells (Hogan et al., 2009; Kajita et al., 2010) . Accordingly, addition of cytochalasin D, the inhibitor of actin polymerization, did not significantly affect the accumulation of NMHC-IIA in Src cells (Supporting Information Figure S3a ,b). In contrast, the myosin-II inhibitor blebbistatin significantly suppressed the accumulation of NMHC-IIA (Supporting Information Figure S3e ,f), suggesting the presence of certain molecular machinery that recruits active myosin-II to the apical side of Src cells. Collectively, these results suggest that NMHC-IIA is accumulated in Src-transformed cells surrounded by normal cells in an F-actin-independent, but myosin-activity-dependent fashion.
To examine the functional role of the myosin-II accumulation in apical extrusion of Src-transformed cells, we established cSrcY527F-transformed cells stably expressing NMHC-IIA-shRNA (Figure 1c ). When NMHC-IIA-knockdown Src cells were surrounded by normal cells, apical extrusion was substantially diminished (Figure 1d ), demonstrating that myosin-II plays a crucial role in apical elimination of Src-transformed cells.
| Accumulation of the myosin-IIspectrin complex plays a positive role in apical extrusion of Src-transformed epithelial cells
Previous studies have reported that myosin-IIA interacts with the spectrin-actin membrane skeleton (Puszkin, Maimon, & Puszkin, 1978; Smith et al., 2018) . Spectrins are large skeletal molecules that exist mainly as heterotetramers consisting of α-spectrin and β-spectrin. They form a filamentous network on the cytoplasmic face of the membrane, thereby providing a scaffold for various proteins (Machnicka et al., 2014; Machnicka, Grochowalska, Boguslawska, Sikorski, & Lecomte, 2012) . By immunoprecipitation, we showed that β-spectrin interacted with NMHC-IIA under the coculture condition ( Figure 2a) . Next, subcellular localization of β-spectrin was examined by immunofluorescence. We found that β-spectrin was accumulated at the apical side of Src-transformed cells that were surrounded by normal cells (Figure 2b ,c). In contrast, accumulation of β-spectrin was not observed when Src cells alone were cultured (Figure 2b,c) . The non-cellautonomous accumulation of β-spectrin was diminished by blebbistatin (Supporting Information Figure S3e ,g), but not by cytochalasin D (Supporting Information Figure S3c,d) . Thus, the mode of accumulation of β-spectrin was akin to that of myosin-II.
To examine the functional role of spectrin in apical extrusion, we established cSrcY527F-transformed cells stably expressing β-spectrin-shRNA (Supporting Information Figure S2a ). The amount of co-immunoprecipitated β-spectrin was profoundly diminished when β-spectrin was knocked down in Src-transformed cells (Supporting Information Figure S2b ), suggesting that the interaction between NMHC-IIA and β-spectrin predominantly occurs in Src-transformed cells under the mix culture condition. We found that knock-down of β-spectrin did not significantly affect accumulation of myosin-II (Figure 3a,b) . In contrast, knock-down of NMHC-IIA substantially diminished accumulation of β-spectrin (Figure 3c ,d), indicating that myosin-II regulates localization of β-spectrin in Src cells surrounded by normal cells. Finally, we investigated the effect of knock-down of β-spectrin on the behavior of Src-transformed cells. When β-spectrin knock-down Src cells were surrounded by normal cells, apical extrusion was significantly suppressed (Figure 3e) . Collectively, these results suggest that accumulation of the myosin-II-spectrin complex plays a positive role in apical extrusion of Srctransformed epithelial cells. or -shRNA2 cells were cocultured with normal MDCK cells, and at 24 hr after tetracycline addition, apical extrusion was analyzed. Data are mean ± SD from three independent experiments. *p < 0.05; **p < 0.005 (Student's t-test). More than 30 cells were analyzed in each experimental condition Genes to Cells TAKAGI eT Al.
| DISCUSSION
In this study, we demonstrate that myosin-II and β-spectrin accumulate at the apical region of transformed cells surrounded by normal cells, which positively regulate apical extrusion. As shown in Figure 2a , the higher amount of β-spectrin binds to myosin-II in a single culture of Src-transformed cells than that of normal cells but is further elevated under the coculture condition, suggesting that the interaction between normal and transformed cells somehow promotes the complex formation between β-spectrin and myosin-II. Both myosin-II and spectrin have actin-binding property. However, we have not observed accumulation of F-actin at the apical region of Srctransformed cells that are surrounded by normal cells (Kajita et al., 2010) . Consistently, the actin-polymerization inhibitor cytochalasin D does not significantly affect the accumulation of myosin-II or spectrin, implying that the interaction between myosin-II and spectrin is regulated by an F-actin-independent mechanism.
Previous studies have shown that the paxillin-plectin-EPLIN complex is accumulated in RasV12-or Src-transformed cells when they are surrounded by normal epithelial cells, which promote apical elimination of the transformed cells (Kadeer et al., 2017; Kasai et al., 2018; Ohoka et al., 2015) . But, knock-down of EPLIN does not significantly influence accumulation of NMHC-IIA, and knock-down of NMHC-IIA does not affect accumulation of EPLIN (Supporting Information Figure S4a-e) . Thus, it is likely that the myosin-II-spectrin complex regulates apical extrusion of Src-transformed cells independently of the paxillin-plectin-EPLIN complex. It has been revealed that other than the accumulation of the paxillin-plectin-EPLIN complex, a variety of non-cell-autonomous changes can occur in transformed cells during apical extrusion such as induction of the Warburg effect-like metabolic changes and elevated endocytosis (Kon et al., 2017; Saitoh et al., 2017) . In future studies, the upstream and downstream regulators of the myosin-II-spectrin complex need to be identified.
Apical extrusion of transformed cells has been also observed in various epithelial tissues in mouse in vivo systems (Kon et al., 2017; Sasaki et al., 2018) . In addition, environmental factors such as obesity and inflammation profoundly influence the frequency of elimination of transformed cells (Sasaki et al., 2018) .
It should be determined whether and how the myosin-II-spectrin complex is involved in these processes in vivo. Further investigation of apical extrusion of transformed cells would lead to a novel approach for cancer prevention.
| EXPERIMENTAL PROCEDURES
| Antibodies and materials
Rabbit anti-NMHC-IIA (LS-B2802) antibody was purchased from LifeSpan BioSciences, Inc. Rabbit anti-NMHC-IIA (M 8064) antibody was from Sigma-Aldrich. The former was used for immunofluorescence, and the latter was for western blotting and immunoprecipitation. Mouse anti-EPLIN (sc-136399) and mouse anti-β-spectrin (sc-136074) antibodies were from Santa Cruz Biotechnology. Mouse anti-actin (Clone C4) antibody was from Millipore. AlexaFluor-568-and -647-conjugated secondary antibodies were from ThermoFisher Scientific. Hoechst 33342 (Life Technologies) was used at a dilution of 1:5,000. For immunofluorescence, the primary antibodies described above were diluted in phosphate-buffered saline (PBS) containing 1% BSA at 1:100. All secondary antibodies were used at 1:200. Alexa-Fluor-647-conjugated phalloidin (Life Technologies) was used at 1.0 U/ml. For western blotting, all primary antibodies were used at 1:1,000, and secondary antibodies were at 1:1,000. The following inhibitors were used where indicated: cytochalasin D (Sigma-Aldrich; 100 nM) and blebbistatin (Millipore; 30 μM). DMSO (Sigma-Aldrich) was added as a control.
| Cell culture
MDCK, MDCK-pTR GFP-cSrcY527F, and MDCK-pTR GFP-RasV12 cells were cultured as previously described (Hogan et al., 2009; Ohoka et al., 2015) . MDCK-pTR GFPcSrcY527F cells stably expressing EPLIN-shRNA were established as previously described (Ohoka et al., 2015) . MDCK-pTR GFP-cSrcY527F cells stably expressing NMHC-IIA-shRNA or β-spectrin-shRNA were established as follows: Double-stranded DNA fragments coding NMHC-IIA-shRNA sequences (NMHC-IIA -shRNA1: 5′-GA TCCCCGCTGCTAAGAAGCTGGTATTTCAAGAGA ATACCAGCTTCTTAGCAGCTTTTTC-3′ and 5′-TCGAG A A A A A G C T G C T A A G A A G C T G G T A TTCTCTTGAAATACCAGCTTCTTAGCAGCGGG-3′ or NMHC-IIA-shRNA2: 5′-GATCCCC GCAACTGACAGC CATGAAATTCAAGAGATTTCATGGCTGTCAGTT GCTTTTTC-3′ and 5′-TCGAGAAAAAGCAACTGACAG CCATGAAATCTCTTGAATTTCATGGCTGTCAGTT GCGGG-3′) or β-spectrin-shRNA sequences (β-spectrinshRNA1: 5′-GATCCCCGCACAGGTTTGAGAGCCTTTT C A A G A G A A A G G C T C T C A A A C C T G T G C T T TTTC-3′ and 5′-TCGAGAAAAAGCACAGGTTTGAGA GCCTTTCTCTTGAAAAGGCTCTCAAACCTGTGC GGG-3′ or β-spectrin-shRNA2: 5′-GATCCCCGCACAC TACAT T T GAG CAT T T CA AGAGA AT G C T CA A A TGTAGTGTGCTTTTTC-3′ and 5′-TCGAGAAAAAGCA CACTACATTTGAGCATTCTCTTGAAATGCTCAAA TGTAGTGTGCGGG-3′) were inserted into the BglII and XhoI site of pSUPER.neo + gfp (Oligoengine). MDCKpTR GFP-cSrcY527F cells were transfected with pSUPER. neo + gfp NMHC-IIA-shRNA or β-spectrin-shRNA using Lipofectamine 2000 (Invitrogen), followed by antibiotic selection in the medium containing 5 μg/ml blasticidin (InvivoGen), 400 μg/ml zeocin (InvivoGen), and 800 μg/ ml G418 (Life Technologies). To induce the expression of GFP-cSrcY527F, the tetracycline-inducible MDCK-pTR GFP-cSrcY527F cells were treated with 2 μg/ml tetracycline (Sigma-Aldrich). For inhibitor treatment, the indicated inhibitors were added together with tetracycline, and cells were further cultured for 16 or 24 hr. For analyses of immunofluorescence or apical extrusion, cells were seeded onto Type-I collagen-mounted coverslips. Type-I collagen (Cellmatrix Type I-A) was obtained from Nitta Gelatin and was neutralized on ice to a final concentration of 2 mg/ml according to the manufacturer's instructions.
| Immunofluorescence
MDCK-pTR GFP-cSrcY527F or MDCK-pTR GFPRasV12 cells were mixed with MDCK cells at a ratio of 1:50 and cultured on the collagen matrix as previously described (Hogan et al., 2009 ). For immunofluorescence analyses, the mixture of cells was incubated for 8-12 hr until they formed a monolayer, followed by tetracycline treatment for 16 hr. Cells were fixed with 4% paraformaldehyde in PBS and permeabilized with 0.5% Triton X-100 in PBS, followed by blocking with 1% BSA in PBS. Primary or secondary antibodies were incubated for 2 or 1 hr, respectively, at ambient temperature. Immunofluorescence images were acquired by the Olympus FV1200 system and the Olympus FV10-ASW software. For quantification of immunofluorescence intensity, more than 30 transformed cells were analyzed for each experiment using the MetaMorph software (Molecular Devices). For analyses of apical extrusions, the samples were prepared as described above, except that cells were treated with tetracycline for 24 hr. More than 30 cells were analyzed for each experiment, and apically extruded cells were quantified.
| Immunoprecipitation and western blotting
For immunoprecipitation, 0.9 × 10 7 MDCK cells and 0.9 × 10 7 MDCK-pTR GFP-cSrcY527F cells for mix culture or 1.8 × 10 7 MDCK or MDCK-pTR GFP-cSrcY527F cells for single culture were seeded in 14.5-cm dishes (one or two dishes for each experimental condition) (Greiner-Bio-One) and cultured for 9 hr until a monolayer was formed. Cells were then incubated with tetracycline to induce c-SrcY527F expression. After 16-hr culture in the presence of tetracycline, cells were washed with icecold PBS containing 1 mM Na 3 VO 4 and lysed for 30 min in Triton X-100 lysis buffer (20 mM Tris-HCl [pH 7.5], 150 mM NaCl, and 1% Triton X-100) containing the following inhibitors: 1 mM Na 3 VO 4 , 10 mM NaF, 5 μg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 7.2 trypsin inhibitor units of aprotinin. After centrifugation of the cell lysates at 21,500 g for 10 min, the supernatant was first pre-cleared with Protein G sepharose (Sigma-Aldrich) at 4°C for 30 min. The pre-cleared cell lysates were then incubated with Dynabeads protein G (Life Technologies) conjugated to control rabbit IgG (5 or 10 μg) at 4°C for 30 min and finally subjected to immunoprecipitation with Dynabeads Protein G conjugated to rabbit anti-NMHC-IIA antibody (5 or 10 μg) at 4°C for 1 hr. Immunoprecipitated proteins were subjected to SDS-PAGE, followed by western blotting with anti-β-spectrin antibody. Western blotting was performed as described previously (Hogan et al., 2004) . Primary antibodies were used at 1:1,000. Western blotting data were analyzed using ImageQuant TM LAS4010
(GE healthcare). To examine the knock-down efficiency of NMHC-IIA, β-spectrin, or EPLIN, MDCK-pTR GFPcSrcY527F cells stably expressing NMHC-IIA-shRNA, β-spectrin-shRNA, or EPLIN-shRNA were seeded onto 6-well dishes (Corning). After 12-24 hr, the incubated cells were lysed with Triton X-100 lysis buffer containing protease inhibitors (5 μg/ml leupeptin, 1 mM phenylmethylsulfonyl fluoride, and 7.2 trypsin inhibitor units of aprotinin) and directly boiled with SDS-PAGE sample buffer.
| Data analyses
Two-tailed Student's t-tests were used to determine P-values for statistical analyses.
| Data availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
